Xerox CEO on Business Reinvention

Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clini ...  Show more

'Bloomberg This Weekend' features unique conversations on business, news, lifestyle and culture. Join David Gura, Christina Ruffini and Lisa Mateo Saturdays and Sundays for discussions with business leaders, lawmakers and cultural icons. Watch the show LIVE on Bloomberg Televisio ...  Show more

Bloomberg's Caroline Hyde and Ed Ludlow bring full market coverage with tech back outperforming as traders brace for a big week in economic data. Plus, a preview of Elon Musk's interview with former President Donald Trump on X, and more earnings coverage with the CEO of Expedia.S ...  Show more

Bloomberg’s Caroline Hyde and Ed Ludlow break down plans for investors to buy TikTok's US operations at a potential valuation of $14 billion. Plus, they discuss the possibility of an AI bubble, after hedge fund manager David Einhorn warned that spending on AI infrastructure may d ...  Show more

Asheesh Chanda, Founder and CEO, at Kristal, discusses the latest on the markets. He spoke with hosts Doug Krizner and Paul Allen on Bloomberg Radio.

See omnystudio.com/listener for privacy information.

Wealth strategist Nicole Webb (Wealth Advancement Group) joins to assess investor sentiment as the government shutdown enters its seventh day. Jim Cramer stops by the NYSE to talk NVIDIA and his new book. Plus, a First on CNBC interview with Michael Dell after his company rais ...